NAPROSYNE 1000 mg, tablet 8 tablets, CIP 3400933449933
Active ingredients: Naproxen
Commercialized according to BDPMDispensing in France: Prescription only
Tablet8 tablets, CIP 3400933449933orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NAPROSYNE 1000 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 8 plaquette(s) PVC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES GRUNENTHAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Oct 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60752908CIP73344993CIP133400933449933Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NAPROXÈNEcomprimé | 1000 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.